Some visit links earn us a commission.

Mounjaro vs Zepbound cost: $499 vs $299 a month and up

Prices checked November 16, 2026

Mounjaro and Zepbound are the same medicine, tirzepatide from Eli Lilly, and paying cash at LillyDirect on November 16, 2026, Mounjaro is $499 a month at every dose while Zepbound is $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up.

No insurance needed. Two programs to check.

The difference is the label. Mounjaro is approved for type 2 diabetes and Zepbound for weight loss and sleep apnea. That decides which one a plan pays for, which savings card you can use and what Medicare does.

Mounjaro vs Zepbound, side by side

Mounjaro and Zepbound compared on medicine, approval, cash price, savings card, Medicare and doses
MounjaroZepbound
Medicine
TirzepatideTirzepatide
Sold for cash by
LillyDirect (Eli Lilly)LillyDirect (Eli Lilly)
Approved for
Type 2 diabetes, in adults and children 10 and older. Also lowers the risk of heart attack and stroke in adults with type 2 diabetes who are at high riskWeight loss in adults with obesity, or with overweight and a weight-related condition. Also moderate to severe obstructive sleep apnea in adults with obesity
Cash price
$499 a month$299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up
Form sold for cash
The single-dose penSingle-dose vials or the KwikPen, at the same price
List price before insurance
$1,112.16 a fill$499 to $1,086.37 a fill
Savings card, with commercial insurance
As low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026As low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026
Medicare GLP-1 Bridge
Not included$50 a month, Zepbound KwikPen only
Doses
No set maintenance dose. Highest dose 15 mg in adults5 mg, 10 mg or 15 mg. For sleep apnea, 10 mg or 15 mg. Highest dose 15 mg weekly

Cash prices are Lilly's own, checked November 16, 2026. You need a prescription for either.

Self-pay price by dose

LillyDirect prices Zepbound by dose, as single-dose vials or the KwikPen: $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up. The $449 price needs a refill within 45 days of your last delivery. Without one, 7.5 mg is $499 and 10 mg and up is $699.

Mounjaro has one self-pay price: $499 a month for the single-dose pen at every dose, for 28 days, up to 4 single-dose pens. The vial prices from $299 are Zepbound's.

So at 2.5 mg and 5 mg the medicine costs less under the Zepbound name. From 7.5 mg, Zepbound is $449 with the 45-day refill and Mounjaro $499, and without the refill Zepbound's 10 mg and up costs more. Your prescriber writes the brand. Every dose: Zepbound cost and Mounjaro cost.

List price

Lilly's list price is $1,112.16 a fill for Mounjaro and $499 to $1,086.37 a fill for Zepbound. For Mounjaro a fill is a month's supply of four pens. List price is what Lilly charges wholesalers, before insurance or any discount.

Who each is approved for

The Mounjaro label covers type 2 diabetes: to improve blood sugar in adults and in children 10 and older, and to lower the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes who are at high risk.

The Zepbound label covers weight loss in adults with obesity, or with overweight and at least one weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity.

The strengths are the same, 2.5 mg to 15 mg once a week, and both labels list single-dose pens, vials and a KwikPen. Each starts at 2.5 mg and rises in 2.5 mg steps after at least 4 weeks. Mounjaro's label sets 15 mg a week as the most for adults, and Zepbound's names 5 mg, 10 mg or 15 mg as the doses to stay on. More on Zepbound dosing.

Savings cards, insurance and Medicare

Both savings cards need commercial insurance that covers the drug. Mounjaro's card terms read as low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026. Zepbound's read as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026. Neither works with Medicare or Medicaid.

A plan pays for Mounjaro when you have type 2 diabetes, often after prior approval. It pays for Zepbound only where it covers weight loss or sleep apnea. Without diabetes, a Mounjaro prescription for weight loss is off-label and plans rarely pay for it. What that does to a prior approval is in same drug, different rules.

On Medicare, the GLP-1 Bridge charges $50 a month for the Zepbound KwikPen to Part D members who qualify, from July 1, 2026 to December 31, 2027. The Zepbound vials do not qualify. Mounjaro is not on the list.

People with type 2 diabetes or sleep apnea are outside that program, and Medicare says their Part D plan might cover the drug instead.

Questions people ask

Is Mounjaro the same as Zepbound?
The medicine is the same: tirzepatide from Eli Lilly, at the same strengths. Mounjaro is approved for type 2 diabetes and Zepbound for weight loss and sleep apnea.
Is Mounjaro cheaper than Zepbound?
Not at the starting doses. Paying cash at LillyDirect, Mounjaro is $499 a month at every dose and Zepbound is $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up. With insurance, the label decides: plans cover Mounjaro for type 2 diabetes.
Is there a savings card for Mounjaro and Zepbound?
Yes, for people with commercial insurance that covers the drug. Mounjaro: as low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026. Zepbound: as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026.
What is the list price of Mounjaro?
Lilly's list price for Mounjaro is $1,112.16 a fill. Zepbound's is $499 to $1,086.37 a fill. At LillyDirect the self-pay price is $499 a month for Mounjaro and from $299 for Zepbound.
Does Medicare cover Mounjaro or Zepbound?
A Part D plan might cover Mounjaro for type 2 diabetes. For weight loss, the Medicare GLP-1 Bridge charges $50 a month for the Zepbound KwikPen to members who qualify. Mounjaro is not on the Bridge list.

Compare other GLP-1 medications

Sources

Evidence checked November 15, 2026

Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.

6 documents

  1. What Mounjaro is approved for and its dosesFDA prescribing information for Mounjaro (DailyMed, revised August 2026)
  2. What Zepbound is approved for and its dosesFDA prescribing information for Zepbound (DailyMed, revised August 2026)
  3. Mounjaro's list price for one fill, before insurance or discountsMounjaro cost information (Eli Lilly)
  4. Zepbound's list price range for one fill, before insurance or discountsZepbound cost information (Eli Lilly)
  5. Which GLP-1 drugs the Medicare GLP-1 Bridge covers, who qualifies and who is outside itWeight loss drugs (Medicare.gov)
  6. The Bridge's $50 copay and its dates, July 1, 2026 to December 31, 2027Medicare GLP-1 Bridge (CMS)

Prices from LillyDirect and Lilly's savings card and list price pages, checked November 16. How we check prices.